Bowel cancer drug funding in danger

As many as 6,500 bowel cancer patients could be denied access to life-extending drugs when a cash pot to pay for them ceases to exist at the end of the year, a charity has warned.

The Cancer Drugs Fund, worth £200 million a year, was set up for patients in England to access drugs approved by their doctors but which have not been given the go-ahead for widespread use on the NHS.
%VIRTUAL-SkimlinksPromo%